Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

396 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.
Pissani F, Schulte B, Eller MA, Schultz BT, Ratto-Kim S, Marovich M, Thongcharoen P, Sriplienchan S, Rerks-Ngarm S, Pitisuttithum P, Esser S, Alter G, Robb ML, Kim JH, Michael NL, Streeck H. Pissani F, et al. Among authors: robb ml. J Virol. 2018 Nov 12;92(23):e01143-18. doi: 10.1128/JVI.01143-18. Print 2018 Dec 1. J Virol. 2018. PMID: 30209165 Free PMC article.
Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients.
Polonis VR, de Souza MS, Darden JM, Chantakulkij S, Chuenchitra T, Nitayaphan S, Brown AE, Robb ML, Birx DL. Polonis VR, et al. Among authors: robb ml. J Virol. 2003 Aug;77(15):8570-6. doi: 10.1128/jvi.77.15.8570-8576.2003. J Virol. 2003. PMID: 12857927 Free PMC article.
Specific antibody responses to vaccination with bivalent CM235/SF2 gp120: detection of homologous and heterologous neutralizing antibody to subtype E (CRF01.AE) HIV type 1.
Kim JH, Pitisuttithum P, Kamboonruang C, Chuenchitra T, Mascola J, Frankel SS, DeSouza MS, Polonis V, McLinden R, Sambor A, Brown AE, Phonrat B, Rungruengthanakit K, Duliege AM, Robb ML, McNeil J, Birx DL; Thai AIDS Vaccine Evaluation Group. Kim JH, et al. Among authors: robb ml. AIDS Res Hum Retroviruses. 2003 Sep;19(9):807-16. doi: 10.1089/088922203769232601. AIDS Res Hum Retroviruses. 2003. PMID: 14585211 Clinical Trial.
Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays.
Singer DE, Kiwanuka N, Serwadda D, Nalugoda F, Hird L, Bulken-Hoover J, Kigozi G, Malia JA, Calero EK, Sateren W, Robb ML, Wabwire-Mangen F, Wawer M, Gray RH, Sewankambo N, Birx DL, Michael NL. Singer DE, et al. Among authors: robb ml. J Clin Microbiol. 2005 Oct;43(10):5312-5. doi: 10.1128/JCM.43.10.5312-5315.2005. J Clin Microbiol. 2005. PMID: 16208006 Free PMC article.
Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda.
Arroyo MA, Sateren WB, Serwadda D, Gray RH, Wawer MJ, Sewankambo NK, Kiwanuka N, Kigozi G, Wabwire-Mangen F, Eller M, Eller LA, Birx DL, Robb ML, McCutchan FE. Arroyo MA, et al. Among authors: robb ml. J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):440-5. doi: 10.1097/01.qai.0000243053.80945.f0. J Acquir Immune Defic Syndr. 2006. PMID: 16980909
Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2.
Kijak GH, Tovanabutra S, Sanders-Buell E, Watanaveeradej V, de Souza MS, Nelson KE, Ketsararat V, Gulgolgarn V, Wera-arpachai M, Sriplienchan S, Khamboonrueng C, Birx DL, Robb ML, McCutchan FE. Kijak GH, et al. Among authors: robb ml. Virology. 2007 Feb 5;358(1):178-91. doi: 10.1016/j.virol.2006.07.055. Epub 2006 Sep 25. Virology. 2007. PMID: 16997343 Free article.
396 results